Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 6/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18405954 | 0.91 | GSK3B (0.60) | GSK3BSMN1; SMN2GAAMAPTLMNA | |
| SCHEMBL30504813 | 0.87 | GSK3B (0.63) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL1978734 | 0.87 | GSK3B (0.67) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL16564077 | 0.86 | HTT (0.57) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL10505311 | 0.86 | HTT (0.61) | GSK3BSMN1; SMN2GAAMAPTLMNA | |
| Ammonia Solution, Strong SCHEMBL28805139 | 0.85 | GSK3B (0.65) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL2201934 | 0.84 | HTT (0.64) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL5063533 | 0.84 | GSK3B (0.73) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL30379812 | 0.84 | GSK3B (0.63) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 | |
| Methylamine SCHEMBL28102069 | 0.84 | GSK3B (0.63) | GSK3BSMN1; SMN2MAPTLMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 937 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110446977-B | Blue photosensitive resin composition, color filter manufactured by using the same and image display device | 东友精细化工有限公司 | 2023-11-14 | — | — | CN | claimed |
| EP-3861039-B1 | HYDROGEL COMPOSITIONS | OPHTALMIC CIE (FR) | 2023-11-01 | — | — | EP | claimed |
| US-20210332174-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2021-10-28 | — | — | US | claimed |
| EP-3861039-A1 | HYDROGEL COMPOSITIONS | Ophtalmic Compagnie (FR) | 2021-08-11 | — | — | EP | claimed |
| CN-113166340-A | Hydrogel composition | 眼科公司 | 2021-07-23 | — | — | CN | claimed |
| WO-2020070423-A1 | HYDROGEL COMPOSITIONS | OPHTALMIC COMPAGNIE (FR) | 2020-04-09 | — | — | WO | claimed |
| US-8941006-B2 | Apparatus and method for extending polyolefin containing photovoltaic panel life span | FINA TECHNOLOGY, INC. (US) | 2015-01-27 | — | — | US | claimed |
| EP-1932195-B1 | SCAVENGER MATERIALS IN FUEL CARTRIDGE | BIC SOC (FR) | 2013-05-01 | — | — | EP | claimed |
| US-20070077480-A1 | Scavenger materials in fuel cartridge | INTELLIGENT ENERGY LIMITED (GB) | 2007-04-05 | — | — | US | claimed |
| US-20060084176-A1 | Detection of uronium salts | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-04-20 | — | — | US | claimed |
| US-6455620-B1 | AN OXIDATION CATALYST, AT LEAST ONE HOMO OR COPOLYMER OR BLEND OF POLYETHERS SELECTED FROM POLY(ALKYLENE GLYCOL)S AND A THERMOPLASTIC POLYMER | EASTMAN CHEMICAL COMPANY | 2002-09-24 | — | — | US | claimed |
| US-5648020-A | PACKAGING | W. R. GRACE & CO.-CONN. (US) | 1997-07-15 | — | — | US | claimed |
| US-12559631-B2 | Thermally curable two-component coating compounds | BASF SE (DE) | 2026-02-24 | — | — | US | disclosed |
| US-20250368830-A1 | METHOD FOR TRANSFERRING AN EMBOSSED STRUCTURE TO THE SURFACE OF A COATING, AND COMPOSITE EMPLOYABLE AS EMBOSSING MOLD | BASF COATINGS GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| EP-3094493-B2 | LAYERED BUILDING BOARD FOR INSIDE AND OUTSIDE | KRONOPLUS TECHNICAL AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-12386253-B2 | Method for transferring an embossed structure to the surface of a coating, and composite employable as embossing mold | BASF COATINGS GMBH (DE) | 2025-08-12 | — | — | US | disclosed |
| US-3959103-A | Photocuring of unsaturated polyester/polythiol compositions | W. R. GRACE & CO. (US) | 1976-05-25 | — | — | US | disclosed |
| US-3950569-A | Method for preparing coatings with solid curable compositions containing styrene-allyl alcohol copolymer based polythiols | W. R. GRACE & CO. (US) | 1976-04-13 | — | — | US | disclosed |
| US-3945982-A | FROM HYDANTOIN GLYCOLS, MOLDING MATERIALS | W. R. GRACE & CO. (US) | 1976-03-23 | — | — | US | disclosed |
| US-3936530-A | Method for preparing coatings using curable solid styrene-allyl alcohol copolymer based polyene and polythiol compositions | W. R. GRACE & CO. (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559631-B2 | Thermally curable two-component coating compounds | ESD, MGMT, MTHFD2 | GSK3B 2227/4885SMN1; SMN2 1826/4885GAA 3847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.